Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Synaptogenix, Inc. (SNPX)  
$7.23 0.51 (6.59%) as of 4:30 Fri 10/17


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 6,040,000
Market Cap: 43.67(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $2.005 - $10.38
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Synaptogenix is a biopharmaceutical company. Co. is focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease (AD), which is in the clinical testing stage. Co. is also evaluating potential therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing. Co. has completed an additional analysis in connection with the confirmatory Phase 2 study, which examined moderately severe to severe AD patients treated with Bryostatin-1 in the absence of memantine.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2025-07-20 2025-04-18 2024-10-18 2023-10-19

   
Records found: 44
  Page 1 of 2  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Weinstein Robert Chief Financial Officer   •       –      –    2025-10-17 4 D $7.23 $28,920 D/D (4,000) 16,574     -
   Weinstein Robert Chief Financial Officer   •       –      –    2025-10-17 4 A $0.00 $0 D/D 10,000 20,574     -
   Singer William S. Director   –       •      –    2025-10-17 4 D $7.23 $43,380 D/D (6,000) 19,566     -
   Singer William S. Director   –       •      –    2025-10-17 4 A $0.00 $0 D/D 15,000 25,566     -
   Bernstein Bruce Director   –       •      –    2025-10-17 4 D $7.23 $72,300 D/D (10,000) 30,897     -
   Bernstein Bruce Director   –       •      –    2025-10-17 4 A $0.00 $0 D/D 25,000 40,897     -
   Ephron Robert Director   –       •      –    2025-10-17 4 D $7.23 $21,690 D/D (3,000) 4,500     -
   Ephron Robert Director   –       •      –    2025-10-17 4 A $0.00 $0 D/D 7,500 7,500     -
   Silverman Joshua Executive Chairman   •       •      –    2025-10-17 4 D $7.23 $289,200 D/D (40,000) 86,681     -
   Silverman Joshua Executive Chairman   •       •      –    2025-10-17 4 A $0.00 $0 D/D 100,000 126,681     -
   Bernstein Bruce Director   –       •      –    2025-06-30 4 D $7.85 $77,425 D/D (9,863) 15,897     -
   Bernstein Bruce Director   –       •      –    2025-06-30 4 A $0.00 $0 D/D 24,657 25,760     -
   Tuchman Alan J Chief Medical Officer   •       •      –    2025-06-30 4 D $7.85 $13,549 D/D (1,726) 3,909     -
   Tuchman Alan J Chief Medical Officer   •       •      –    2025-06-30 4 A $0.00 $0 D/D 4,315 5,635     -
   Singer William S. Director   –       •      –    2025-06-30 4 D $7.85 $48,387 D/D (6,164) 10,566     -
   Singer William S. Director   –       •      –    2025-06-30 4 A $0.00 $0 D/D 15,410 16,730     -
   Silverman Joshua Executive Chairman   •       •      –    2025-06-30 4 D $7.85 $131,629 D/D (16,768) 26,681     -
   Silverman Joshua Executive Chairman   •       •      –    2025-06-30 4 A $0.00 $0 D/D 41,919 43,449     -
   Weinstein Robert Chief Financial Officer   •       –      –    2025-06-30 4 D $7.85 $48,387 D/D (6,164) 10,574     -
   Weinstein Robert Chief Financial Officer   •       –      –    2025-06-30 4 A $0.00 $0 D/D 15,410 16,738     -
   Schechter Jonathan Director   –       •      –    2025-06-30 4 D $7.85 $67,746 D/D (8,630) 14,035     -
   Schechter Jonathan Director   –       •      –    2025-06-30 4 A $0.00 $0 D/D 21,575 22,665     -
   Bernstein Bruce Director   –       •      –    2022-12-16 4 AS $1.17 $26,368 D/D (22,500) 27,578     -
   Weinstein Robert Chief Financial Officer   •       –      –    2022-12-16 4 AS $1.17 $31,641 D/D (27,000) 33,198     -
   Singer William S. Director   –       •      –    2022-12-16 4 AS $1.17 $31,641 D/D (27,000) 33,000     -
  44 Records found
  1  2   
  Page 1 of 2
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us